Company: LIN
Filing Date: 2025-05-01
Form Type: 10-Q
Source: 0001628280-25-021379
Chunk: 36

Company: LINDE PLC
Filing Date: 2025-05-01
Form: 10-Q
Item: Item 8
Chunk 36
---
 fair value of derivatives was insignificant. Management believes the risk of incurring losses on derivative contracts related to credit risk is remote and any losses would be immaterial.

10

The following table is a summary of the notional amount and fair value of derivatives outstanding at March 31, 2025 and December 31, 2024 for consolidated subsidiaries:   Fair Value Notional AmountsAssets (a)Liabilities (a)(Millions of dollars)March 31,2025December 31,2024March 31,2025December 31,2024March 31,2025December 31,2024Derivatives Not Designated as Hedging Instruments:Currency contracts:Balance sheet items$9,637 $9,935 $103 $256 $46 $64 Forecasted transactions 205 168 2 2 2 6 Total$9,842 $10,103 $105 $258 $48 $70 Derivatives Designated as Hedging Instruments:Currency contracts:       Forecasted transactions$748 $780 $17 $7 $2 $11 Forward exchange transactions1,623 1,059 21 30 19 — Commodity contracts N/AN/A5 11 23 20 Total Hedges$2,371 $1,839 $43 $48 $44 $31 Total Derivatives$12,213 $11,942 $148 $306 $92 $101 (a)Amounts as of March 31, 2025 and December 31, 2024, respectively, included current assets of $141 million and $302 million which are recorded in prepaid and other current assets; long-term assets of $7 million and $4 million which are recorded in other long-term assets; current liabilities of $84 million and $92 million which are recorded in other current liabilities; and long-term liabilities of $8 million and $9 million which are recorded in other long-term liabilities.In addition, during 2024, Linde issued credit default swaps (“CDS”) to third-party financial institutions. The CDS relate to secured borrowings provided by the financial institutions to a government customer in Mexico, that were utilized to pay certain of Linde’s outstanding receivables. The notional amount of the CDS, which was $167 million and $166 million